MedTrace Logo

A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence

NCT01680887 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2019-08-06

Study results available
· View outcomes & findings →

Summary

This is a double-blind placebo-controlled clinical trial (n = 156) of varenicline for the treatment of cocaine dependence that utilizes contingency management to promote treatment attendance.

Conditions

  • Cocaine Dependence

Interventions

DRUG

Varenicline

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Kyle M Kampman, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2018-01-31
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01680887 on ClinicalTrials.gov